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STUDIES ON THE TUBERCULOSTATIC FACTOR
IN HUMAN URINE
Shunsaku OSHIMA, Masayuki NISHIDA, Shusuke TSUJI
Chest Disease Research Institute, Kyoto University
Kazuo MORIMOTO
The Green Cross Corporation, Research Laboratory
Tokio KOGI, Takashi KITANO, Toshihiro NISHIDA,
Aketni DAIMOTO, Shigeru KUWATA,
Hiroshi WATANABE
Laboratory cif Chemistry, .Faculty of Science, Konan University
In order to obtain a large quantity of a peptide-like substance in human urine which
has been proven to have a marked tuberculostatic activity in a small-scale experiment,
column chromatography using charcoal and ion exchange resins (Amberlite CG400,
Dowex 50) was performed.
About 3.0 g of the active fraction (Fr. aE) was isolated from 18,000 kg of urine by this
procedure. This fraction inhibited the growth of virulent tubercle bacilli in the concentra-
tion of 16 mcg/ml but did not inhibit the growth of other bacteria than tubercle bacilli
and fungi even in the concentration of 250 mcg/ml. This fraction contains a peptide-like
substance which may play an important role in natural resistance of human body against
tuberculous infection.
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FACTORS CONCERNING WITH DISABILITY OF THE PATIENTS
AND THE PROGNOSIS OF THE CHRONIC
OBSTRUCTIVE LUNG DISEASE
Shinichiro HEKI, Michiro NAKASHIMA, Shozo T ATEISHI,
Yasuhira HAMAMOTO, ShizuD1asa IKOMA,
Takashi SAKAI
Kyoto City Hospital, Division if Respiratory Disease
Prior to this study, the authors published the clinical study concerning with the
progress and excervation of chronic obstructive lung disease (COLD), in which COLD
was classified into 4 groups from the view point of the onset, the clinical findings and
courses of the diseases.
In this paper, the authers attempted to evaluate the prognosis of COLD and grade of
disability of the patients on the basis of their previous study.
COLD takes a turn for the worse by repeating acute excervation with infection, the
observation of 41 cases with pulmonary function test in the midst, before and after the
acute excervation was studied. These 41 cases were classified into 4 groups as follows;
Type a; Group originated in bronchial asthma remaining obstructive ventilation insuffi-
ciency on ease and suffering from infection sometimes. This insufficiency is markedly
reversible.
Type b; Group with repeating bronchitis with wheezing on excervation and taking a turn
for the worse gradually. Irreversible. Besides obstructive ventilation insufficiency,
restrictive ventiration insufficiency is acommpanied. Hypoxemia and Hypercapnia
grow to right ventricular hypertrophy. Subjective complaints are marked. Many
patients belonging this group are disabled.
Type c; Group of diffuse bronchiectasis with the symptomes of chronic bronchitis since
very young age. This type of COLD has the clinical and roentgenological features of
pulmonary fibrosis. 1\10st patients with this type can work except on the excervation.
They have restructive and obctructive ventiration insufficiency. \;\Then such insufficiency
reaches to some limit, the general state of the patient turns to worse suddenly. The
prognosis is poor.
Type d; Group of restrictive ventiration insufficiency due to restrictive movement of
thorax. This group is alike the severe cases of Type c. The prognosis is poor.
From these observations, it could be concluded that the diagnosis of the type of GOLD
and cognition of restrictive ventilation insufficiency besides obstructive are immportant
for the evaluation of the prognosis of COLD and disability of the patients with COLD.
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SIDE EFFECTS OF ANTITUBERCULOSIS AGENTS
Nobuo MAEKAWA, M. D .
.First Dept. of Medicine, Chest Disease Research Insitute, Kyoto University
~ 51 --
In the clinical study of the intensification of the effect of antituberculosis chemotherapy,
it is one of the most important tasks to avoid the side effects caused by anti tuberculosis
agents.
The author, with several collaborates, has been studied about this problem including
drug-allergy and experienced that there are fairly many cases dropped out of the intens-
ified regimen because of the various side effects.
In this report, the author's experiences on the incidences and the preventive measures
for each drug are discussed with some references.
As for Streptomycin (SM) and Kanamycin (KM), ototoxicity is main cause of
cessation of the treatment and its incidence is estimated about 4-5~/o for audiometry.
According to the clinical results, the injection of SM or K~1 in the evening before going
to sleep is efficacious in reducing the ototoxicity but the mechanism is not well explained.
Gastric disturbance caused by ethionamide is prevented or reduced fairly by using
prothionamide or by giving the tolerable maximum of ethionamide before going to sleep
and the rest divided after meal.
Cycloserine (CS) is noted as the occasional cause of neuropathic disorder especially
III older patients at the rate over 10%) and it is shown that the incidence of this side
effect can be reduced by decreasing the daily dose of CS as 0.375 g. in the patients over
60 years of age and/or under 40 kg of body weight.
Ethambutol (EB) is known to attack the optic nerve selectively but the distur-
bances are mostly reversible and they are detectable in the early stage by careful
observation at the bed-side in the prevailing daily dose of 19. of EB (d-form).
As the counter measure to the drug-allergy caused mainly by SM and/or PAS,
the modified method of which reported initially by D. G. Simpson, is evaluated as
fairly successful to get over the allergic symptoms in relatively short interruption of
the chemotherapy of tuberculosis.
- 52- Bull. Chest Dis Res. Inst., Kyoto Univ.
EXPERIMENTAL STUDIES ON ANAPHYLACTIC SHOCK
UNDER GENERAL ANESTHESIA
Ritsuko INOUE
Chest Disease Research Institute, Kyoto University, Gifu-Byoin National Sanatorium
There are many reports including Besredka's that general anesthesia suppresses
anaphylactic shock. However, it can not be concluded that this is so, because some other
doctors reported quite opposite results.
Recently, in the clinical field, importance is being placed on anaphylactic shock by
penicillin. As a counter-drug for anaphylactic shock, adrenal cortical hormone, anti-
histamine substances, autonomic nerve blockers, angiotonin and coronary dilators are used.
In addition to these, general anesthesia is also thought useful.
According to clinical experiences, it was reported that during general anesthesia,
penicillin and other drugs do not cause any anaphylactic shock. It was also reported that
even in the transfusion of different blood groups, no severe shock was seen, if it was done
during general anesthesia.
Here researcher have made a basic investigation to find out whether or not general
anesthesia really suppresses anaphylactic shock.
Results obtained were as follows:
I) In passive sensitized guinea pigs with anti BAS serum from rabbits, ether
anesthesia surely prevented anaphylactic shock by BSA.
2) Death by anaphylactic shock was not prevented either by general anesthesia using
laughing gas and succinylcholin, or by the administration of morphine, atropine, tetraethyl-
ammonium or chlorpromazine. Especially in general anesthesia by laughing gas or
succinylcholin, even when respiration was controlled, the animal died of acute collapse
of the lungs after the administration of antigen.
3) In active sensitized guinea pigs and rabbits with BSA, the suppressive effect of
ether anesthesia for anaphylactic shock was weak in guinea pigs, and was weaker in rabbits.
4) We knew from the above data, the suppressive effect ofether anesthesia depended
on the amount of antibody in the experimental animal and on the animal species.
5) After anaphylactic shock, the antibody decreased naturally. Especially in the
passive sensitized animal, it almost disappeared. However, in the active sensitized rabbits,
reproduction of the antibody began shortly after the shock, and in 8 days it returned to the
same amount as before the operation or more.
Large amounts ofantigen were given to be rabbits who escaped from death by shock to
cause immunological paralysis. However, this ended unsuccessful at least in rabbits.
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6) Using 1131 labelled BSA, the site of antigen-antibody reaction was investigated
and under ether anesthesia, the gathering of antigen in the lung or in the heart, which
was found in the control group, was not seen.
7) lVlechanisms of suppressive effects of ether anesthesia for anaphylactic shock were
that: A) Ether acted on smooth muscles of the bronchi and made it dilate to antagonize
agai.nst the constriction caused by anaphylactic shock; B) Ether acted on the coronary
artery, making a higher efficiency of the heart function: C) Ether dilated peripheral
blood vessels and prevented antigen from gathering in the central organs.
8) Even in the case where shock was suppressed by ether anesthesia and the patient
escaped from death, pathohistologically it is common to leave in the liver necrosis resulting
from antigen-antibody reaction. From this point of view. it seems necessary to pay at-
tention to the disturbance of hepatic function as an after-effect of ether anesthesia as a
countermeasure for anaphylactic shock.
